Why Thryv (THRY) Might be Well Poised for a Surge — Positive
THRY Zacks Investment Research — August 13, 2025Thryv Holdings, Inc. (THRY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Earnings Estimates Rising for TowneBank (TOWN): Will It Gain? — Positive
TOWN Zacks Investment Research — August 13, 2025TowneBank (TOWN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Earnings Estimates Moving Higher for Envista (NVST): Time to Buy? — Positive
NVST Zacks Investment Research — August 13, 2025Envista (NVST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Rigetti Stock: A Long-Term Quantum Play Facing Short-Term Tests — Positive
RGTI MarketBeat — August 13, 2025Shares of Rigetti Computing Inc. NASDAQ: RGTI are down more than 2% the day after the quantum computing company delivered a mixed earnings report. Revenue of $1.8 million was roughly in line with expectations for $1.87 million.
Disney Banks on NFL Deal: Will ESPN's New Streaming Push Pay Off? — Neutral
DIS Zacks Investment Research — August 13, 2025DIS' multi-year NFL pact brings ESPN Draft rights, RedZone, and streaming tie-ins to Disney+ and Hulu, aiming to score big in sports streaming.
Crypto exchange Bullish more than doubles in NYSE debut after pricing IPO above expected range — Positive
BLSH CNBC — August 13, 2025Bullish shares rocketed after the crypto exchange raised $1.1 billion in an initial public offering. The stock opened at $90 on the New York Stock Exchange under the ticker BLSH after its IPO priced at $37 per share.
American Well Q2 Review: Hold Rating Maintained Amid DHA Renewal Concerns — Neutral
AMWL Seeking Alpha — August 13, 2025American Well's revenue growth and cost control are strong, but the short DHA contract extension raises concerns about long-term stability and reliability of key revenue streams. Amwell's shift to higher-margin software revenue is promising, but guidance was revised downward due to contract uncertainties and program exclusions. Cost reductions have improved EBITDA and cash flow outlook, but excessive cuts risk undermining R&D, marketing, and future growth potential.
Hot Demand, Cold Reality: The LNG Balancing Act At Venture Global — Negative
VG Seeking Alpha — August 13, 2025I rate Venture Global a 'Hold' due to strong LNG market growth offset by cyclical risks, overinvestment, and declining profitability metrics. Deregulation and global demand support revenue growth, but intense competition and potential overproduction threaten future pricing and margins. Profitability, ROIC, and free cash flow have deteriorated, while heavy debt and aggressive growth assumptions leave no room for execution missteps.
Can GE Vernova Ride the Momentum on Expanding Global Nuclear Power? — Positive
GEV Zacks Investment Research — August 13, 2025GEV aims to capture the global nuclear surge with its BWRX-300 small modular reactors and expanding international collaborations.
Beyond Mach 5: How RTX Is Redefining Hypersonic Dominance — Neutral
RTX Zacks Investment Research — August 13, 2025RTX leverages decades of missile and radar expertise to lead U.S. hypersonic innovation, advancing both offensive and defensive capabilities.
Will BJ's (BJ) Beat Estimates Again in Its Next Earnings Report? — Positive
BJ Zacks Investment Research — August 13, 2025BJ's (BJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Walmart (WMT) Beat Estimates Again in Its Next Earnings Report? — Positive
WMT Zacks Investment Research — August 13, 2025Walmart (WMT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Superior Plus Corp. (SUUIF) Q2 2025 Earnings Call Transcript — Neutral
SPB SUUIF Seeking Alpha — August 13, 2025Superior Plus Corp. (OTCPK:SUUIF) Q2 2025 Earnings Conference Call August 13, 2025 8:30 AM ET Company Participants Allan Angus MacDonald - CEO, President & Director Chris Lichtenheldt - Vice President of Investor Relations Dale Winger - President of Certarus Grier Barrett Colter - Executive VP & CFO Conference Call Participants Aaron MacNeil - TD Cowen, Research Division Benjamin Isaacson - Scotiabank Global Banking and Markets, Research Division Gary Ho - Desjardins Securities Inc., Research Division Nelson Ng - RBC Capital Markets, Research Division Robert Catellier - CIBC Capital Markets, Research Division Operator Good day, and thank you for standing by. …
Elbit Systems Ltd. (ESLT) Q2 2025 Earnings Call Transcript — Neutral
ESLT Seeking Alpha — August 13, 2025Elbit Systems Ltd. (NASDAQ:ESLT ) Q2 2025 Earnings Conference Call August 13, 2025 9:00 AM ET Company Participants Bezhalel Machlis - President & CEO Daniella L.
IceCure Medical Ltd (ICCM) Q2 2025 Earnings Call Transcript — Neutral
ICCM Seeking Alpha — August 13, 2025IceCure Medical Ltd (NASDAQ:ICCM ) Q2 2025 Earnings Conference Call August 13, 2025 10:00 AM ET Company Participants Michael Polyviou - IR, EVC Group Inc. Eyal Shamir - CEO & Director Ronen Tsimerman - CFO & COO Conference Call Participants Brian Kemp Dolliver - Brookline Capital Markets, LLC, Research Division Anthony V. Vendetti - Maxim Group LLC, Research Division Eduardo Rafael Martinez-Montes - H.C.
Similarweb Ltd. (SMWB) Q2 2025 Earnings Call Transcript — Neutral
SMWB Seeking Alpha — August 13, 2025Similarweb Ltd. (NYSE:SMWB ) Q2 2025 Earnings Conference Call August 13, 2025 8:30 AM ET Company Participants Jason E.
Nuvalent to Present Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025 Presidential Symposium — Neutral
NUVL PRNewsWire — August 13, 2025CAMBRIDGE, Mass. , Aug. 13, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that pivotal data for zidesamtinib, a novel ROS1-selective inhibitor, in TKI (tyrosine kinase inhibitor) pre-treated patients with advanced ROS1-positive non-small cell lung cancer (NSCLC) from the global ARROS-1 Phase 1/2 clinical trial, in addition to preliminary data for TKI-naïve patients, will be presented as part of the Presidential Symposium at the IASLC 2025 World Conference on Lung Cancer (WCLC 2025).
Hudbay Minerals Inc. (HBM) Q2 2025 Earnings Call Transcript — Neutral
HBM Seeking Alpha — August 13, 2025Hudbay Minerals Inc. (NYSE:HBM ) Q2 2025 Earnings Conference Call August 13, 2025 11:00 AM ET Company Participants Andre Taylor Lauzon - Chief Operating Officer Candace Brule - Vice President of Investor Relations, Financial Analysis & External Communications Chi-Yen Lei - Chief Financial Officer Peter Gerald Jan Kukielski - President, CEO & Director Conference Call Participants Dalton Baretto - Canaccord Genuity Corp., Research Division Fahad Tariq - Jefferies LLC, Research Division Matthew Murphy - BMO Capital Markets Equity Research Orest Wowkodaw - Scotiabank Global Banking and Markets, Research Division Ralph M. Profiti - Stifel Nicolaus Canada Inc., Research Division Shane …
Bit Digital's WhiteFiber IPO is a potential game-changer, analysts say — Positive
BTBT WYFI Proactive Investors — August 13, 2025Bit Digital Inc (NASDAQ:BTBT)'s initial public offering (IPO) of its high-performance computing (HPC) subsidiary WhiteFiber is seen as a potential catalyst for new growth, according to analysts at Noble Capital Markets. The analysts maintained their ‘Outperform' rating and $5.50 price target on Bit Digital, implying upside from its current share price of about $3, following WhiteFiber's IPO on the Nasdaq under the ticker symbol “WYFI.
KLC INVESTOR ALERT: Investor Files Class Action Lawsuit Against KinderCare Learning Companies, Inc. and Attorneys Announce Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit — Neutral
KLC PRNewsWire — August 13, 2025SAN DIEGO , Aug. 13, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of KinderCare Learning Companies, Inc. (NYSE: KLC) common stock in or traceable to KinderCare's October 2024 initial public offering (the "IPO"), have until October 13, 2025 to seek appointment as lead plaintiff of the KinderCare class action lawsuit. Captioned Gollapalli v.